Pathogenesis of cutaneous T-cell lymphoma: Implications for the use of recombinant cytokines and photopheresis

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 16-20

  Rook, A H ^a,b   Gottlieb, S L ^a   Wolfe, J T ^a   Vowels, B R ^a   Sood, S S ^a   Niu, Z ^a   Lessin, S R ^a   Fox, F E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b 2 Rhoads Pavilion ^*  (United States)

Author keywords

Cutaneous T cell lymphoma; IFN ; IL 12; Photopheresis

Indexed keywords

CYTOKINE; INTERLEUKIN 12; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2;

APOPTOSIS; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; PHENOTYPE; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

ANIMALS; COMBINED MODALITY THERAPY; CYTOKINES; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PHOTOPHERESIS; RECOMBINANT PROTEINS; SKIN NEOPLASMS;

EID: 0031025852     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bjerke JR, Krogh HK, Matre R. Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol 1978; 71:340-43.
2. Bos J, Hulsebosch HJ, Krieg SR et al. Immunocompetent cells in psoriasis in situ immunotyping by monoclonal antibodies. Arch Dermatol Res 1983; 275:181-9.
3. Baker BS, Swain AF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110:555-64.
4. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992; 126:1-9.
5. Valdimarsson H, Baker BS, Jónsdóttir I, Fry L. Psoriasis - a disease of abnormal proliferation induced by T lymphocytes. Immunol Today 1986; 7:256-9.
6. Valdimarsson H. Psoriasis - a T-lymphocyte mediated disease. In: Lachmann PJ, Peters K, Rosen FS, Walport MJ, eds. Clinical Aspects of Immunology. Oxford: Blackwell Science Ltd 1993: 1887-97.
7. Morel P, Revillard J-P, Nicolas J-F et al. Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmunity 1992; 5:465-77.
8. Prinz JC, Gross B, Vollmer S et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 1994; 24:593-8.
9. Schmitt-Egenolf M, Boehncke W-H, Ständer M et al. Oligonucleotide typing reveals association of type I psoriasis with the extended haplotype HLA-DRBl*0701/2; -DQA1*0102; -DQB1*0303. J Invest Dermatol 1993; 100:749-52.
10. Baker BS, Powles AV, Valdimarsson H, Fry L. An altered response by psoriatic keratinocytes to gamma interferon. Scand J Immunol 1988; 28:735-40.
11. Nickoloff BJ, Mitra RS, Elder RT et al. Decreased growth inhibition by recombinant transforming growth factor-γ in keratinocytes cultured from psoriatic lesions. Br J Dermatol 1989; 121:161-74.
12. Vollmer S, Mensen A, Trommler P et al. T lymphocytes derived from skin lesions of patients with psoriasis express a novel cytokine pattern that is distinct from that of T-helper type I and T-helper type 2 cells. Eur J Immunol 1994; 24:2377-83.
13. Tefler NR, Chalmers RJG, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128:39-42.
14. Manjula BN, Trus BL, Fischetti VA. Presence of the distinct regions in the coiled-coil structure of the streptococcal PepM5 protein: Relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci 1985; 82:1064-8.
15. McFadden J, Valdimarsson H, Fry L. Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 1991; 125:443-7.
16. Baker BS, Bokth S, Powles A et al. Group A streptococcal antigen specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128:493-9.
17. Lewis HM, Baker BS, Bokth S et al. Restricted T cell receptor Vβ usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993; 129:514-20.
18. Abe J, Forrester J, Nakahara et al. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol 1991; 146:47-50.
19. Leigh IM, Navsaria H, Purkis PE et al. Keratins K16 and 17 as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995; 133:501-11.
20. Aoki S, Yaoti H, Kirajama Y. An elevated level of autoantibodies against 48- to 50 Kd keratins in serum of patients with psoriasis. J Invest Dermatol 1989; 92:179-83.
21. Steinmuller D, Zinsmeister AR, Roger RS. Cellular autoimmunity in psoriasis and lichen planus. J Autoimmunity 1988; 1:279-98.
22. Schlaak JF, Buslan M, Jochum W, et al. T cells involved in psoriasis belong to the Th1 subset. J Invest Dermatol 1994; 102:145-9.
23. Barna M, Snidjewint FGM, Van der Heijden FL, Bos JD, Kapsenberg ML. Characterization of lessional psoriatic skin T lymphocyte clones. Acta Derm Venerol Suppl 1991; 186:9-11.
24. Valdimarsson H, Baker BS, Jónsdóttir I, Powles AP, Fry L. Psoriasis - a T cell mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16:145-9.
25. Leung DYM, Gately M, Trumble A et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen via stimulation of interleukin 12 production. J Exp Med 1995; 181: 747-53.
26. Houghten RA. General method for rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 1988; 82:5131-5.
27. Jónsdóttir I, Dillner-Centerlind, Perlmann H, Perlmann P. Antibody dependent cellular cytotoxicity and mitogen responsiveness of human peripheral blood lymphocytes differ in avidity for sheep erythrocytes. Scand J Immunol 1979; 10:525-33.
28. Kabilan L, Anderson G, Lolli F et al. Detection of intracellular expression and secretion of IFN-γ at single cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol 1990; 20:1085-9.